Active-ingredient Dossier
Leflunomide
Active-ingredient Dossier for Leflunomide (immunosuppressive agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: ARAVA
- Brand: LEFLUNOMIDE APOTEX
- Brand: APO-LEFLUNOMIDE
- Brand: ATARIS
- Brand: LEFLUNOMIDE
- Brand: LEFLUNOMIDE-WGR
- Therapeutic area: Musculoskeletal
- Therapeutic area: Immunology
What is
Leflunomide Leflunomide is an immunosuppressive agent.
Australian brands containing
Leflunomide — ARAVA — LEFLUNOMIDE APOTEX — APO-LEFLUNOMIDE — ATARIS — LEFLUNOMIDE — LEFLUNOMIDE-WGR — LUNAVA
Therapeutic areas
Leflunomide is registered in immunology, with seven brands containing this ingredient on the ARTG.
Sponsor landscape
Leflunomide is marketed by five sponsors: Arrotex Pharmaceuticals, Southern Cross Pharma, Sanofi-Aventis, GM Pharma, and Medis Pharma.
PBS and regulatory activity
One brand containing leflunomide has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 September 2022, with two brands having PBAC outcomes on record.